Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Social Development (Oxford, England)|June 10, 2021
Culture, parenting, and language: Respeto in Latine mother-child interactionsCatherine S Tamis-LeMonda, Margaret O'Brien Caughy, Raúl Rojas, et al.ACS Chemical Biology|June 4, 2020
Substrate Plasticity of a Fungal Peptide α-<i>N</i>-MethyltransferaseHaigang Song, Ju Ratè Fahrig-Kamarauskaitè, Emmanuel Matabaro, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2011
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosisJ Theodore Phillips, Gavin Giovannoni, Fred D Lublin, et al.International Journal of MS Care|October 17, 2015
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl FumarateJ Theodore Phillips, Krzysztof Selmaj, Ralf Gold, et al.The Lancet. Neurology|February 10, 2009
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyEva Havrdova, Steven Galetta, Michael Hutchinson, et al.Progress in Community Health Partnerships : Research, Education, and Action|October 1, 2019
Community-Based, Caregiver-Implemented Early Language Intervention in High-Risk Families: Lessons LearnedRufan Luo, Rebecca M Alper, Kathy Hirsh-Pasek, et al.The Journal of Biological Chemistry|May 16, 2002
BRCA1 regulates the interferon gamma-mediated apoptotic responseHeather N Andrews, Paul B Mullan, Stewart McWilliams, et al.Annals of Neurology|August 26, 2010
Anti-JC virus antibodies: implications for PML risk stratificationLeonid Gorelik, Michaela Lerner, Sarah Bixler, et al.Journal of Neurology|November 10, 2014
Radiologic MS disease activity during natalizumab treatment interruption: findings from RESTOREMichael Kaufman, Bruce A C Cree, Jerome De Sèze, et al.The New England Journal of Medicine|May 4, 2019
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum DisorderSean J Pittock, Achim Berthele, Kazuo Fujihara, et al.Pageof 4